The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o- epithelial cell monolayers in vitro

Clinical and Experimental Allergy

Volumn 40, Issue 3, 2010, Pages 435-449

  Ewen, D ^a   Clarke, S L ^a   Smith, J R ^a   Berger, C ^b   Salmon, G ^b   Trevethick, M ^b   Shute, J K ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Bronchial epithelium; Coagulation; Elastase; Factor Xa; Fibrin; Protease activated receptor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRIN; INDOMETACIN; LEUKOCYTE ELASTASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP1 RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN EP4 RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BRONCHUS MUCOSA; CELL LINE; EPITHELIUM CELL; FIBRIN FORMATION; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WOUND HEALING;

ANTIBODIES; CELL MEMBRANE; CELLS, CULTURED; DINOPROSTONE; EPITHELIAL CELLS; FACTOR XA; HUMANS; INDOMETHACIN; LEUKOCYTE ELASTASE; OLIGOPEPTIDES; RECEPTOR, PAR-1; RECEPTOR, PAR-2;

EID: 76349115604     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03453.x     Document Type: Article

References (59)

1. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004 23 : 327 333.
2. Kato A, Schleimer RP. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol 2007 19 : 711 720.
3. Erjefalt JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin Exp Allergy 1997 27 : 1344 1355.
4. Gershwin LJ. Effects of allergenic extracts on airway epithelium. Curr Allergy Asthma Rep 2007 7 : 357 362.
5. Reed CE. Inflammatory effect of environmental proteases on airway mucosa. Curr Allergy Asthma Rep 2007 7 : 368 374.
6. Erjefalt JS, Erjefalt I, Sundler F, Persson CGA. Microcirculation-derived factors in airway epithelial repair in vivo. Microvasc Res 1994 48 : 161 178.
7. Perrio MJ, Ewen D, Trevethick MA, Salmon GP, Shute JK. Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins. Clin Exp Allergy 2007 37 : 1688 1700.
8. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharm Rev 2001 53 : 245.
9. De Campo BA, Henry PJ. Protease-activated receptors (PARs) are partly pro-inflammatory and partly anti-inflammatory: will PAR agonists or antagonists participate in future drug therapies? Curr Drug Targets 2006 7 : 629 637.
10. Chambers R. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol 2008 153 : S367 78.
11. Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Therapeut 2002 95 : 239 257.
12. Sokolova E, Reiser G. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors. Pharmacol Therapeut 2007 115 : 70 83.
13. Chignard M, Pidard D. Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells. More terminators than activators. Am J Respir Cell Mol Biol 2006 34 : 394 398.
14. Dulon S, Cande C, Bunnett NW, Hollenberg MD, Chignard M, Pidard D. Proteinase-activated receptor-2 and human lung epithelial cells. Disarming by neutrophil serine proteases. Am J Respir Cell Mol Biol 2003 28 : 339 346.
15. Knight DA, Lim S, Scaffidi AK et al. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 2001 108 : 797 803.
16. Cocks TM, Fong B, Chow JM et al. A protective role for protease-activated receptors in the airways. Nature 1999 398 : 156 160.
17. Cocks TM, Moffatt JD. Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharm Therapeut 2001 14 : 183 191.
18. Asokananthan N, Graham PT, Fink J et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002 168 : 3577 3585.
19. Savla U, Appel HJ, Sporn PHS, Waters CM. Prostaglandin E2 regulates wound closure in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2001 280 : L421 31.
20. Henry PJ. The protease-activated receptor2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: a potential bronchoprotective unit in the respiratory tract? Eur J Pharmacol 2006 533 : 156 170.
21. Page K, Strunk VS, Hershenson MB. Cockroach proteases increase IL-8 expression in human bronchial epithelial cells via activation of protease-activated receptor (PAR)-2 and extracellular-signal-regulated kinase. J Allergy Clin Immunol 2003 112 : 1112 1118.
22. Suzuki T, Moraes TJ, Vachon E et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005 33 : 231 247.
23. Anderssen T, Halvorsen H, Bajaj SP, Osterud B. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb Haemostasis 1993 70 : 414 417.
24. Turkington PT. Degradation of human factor X by human polymorphonuclear leucocyte cathepsin G and elastase. Haemostasis 1991 21 : 111 116.
25. Bagoly Z, Fazakas F, Komaromi I, Haramura G, Toth E, Muszbek L. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIIIA subunit. Thromb Haemostasis 2008 99 : 668 674.
26. Krupiczojc MA, Scotton CJ, Chambers RC. Coagulation signalling following tissue injury: focus on the role of factor Xa. Int J Biochem Cell Biol 2008 40 : 1228 1237.
27. Blackburn JS, Brinckerhoff CE. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol 2008 173 : 1736 1746.
28. Chokki M, Eguchi H, Hamamura I, Mitsuhashi H, Kamimura T. Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2 mediated ERK activation and TNF α-converting enzyme activity in airway epithelial cells. FEBS J 2005 272 : 6387 6399.
29. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007 120 : 1233 1244.
30. Blackhart BD, Emilsson K, Nguyen D et al. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 1996 271 : 16466 16471.
31. Hollenberg MD, Saifaddine M, Al-Ani B, Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 1997 75 : 832 841.
32. Al-Ani B, Hansen KK, Hollenberg MD. Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation. Mol Pharmacol 2004 65 : 149 156.
33. Al-Ani B, Saifeddine M, Wijesuriya J, Hollenberg MD. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J Pharmacol Exp Ther 2002 300 : 702 708.
34. Vassallo RR, Kieber-Emmons T, Cichowski K, Brass LF. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 1992 267 : 6081 6085.
35. Abramovitz M, Adam M, Boie Y et al. The utilisation of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000 1483 : 285 293.
36. Alpert SE, Walenga RW, Kramer CM, Silski CL, Davies PB. Tracheal epithelial cell fatty acid composition modulates prostaglandin E2 and cAMP production. Am J Physiol 1992 262 : L192 7.
37. Dewitt DL, Meade EA. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 1993 306 : 94 102.
38. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001 15 : 2057 2072.
39. Opal SM. Interactions between coagulation and inflammation. Scand J Infect Dis 2003 35 : 545 554.
40. Spronk HMH, Govers-Riemslag JWP, ten Cate H. The blood coagulation system as a molecular machine. BioEssays 2003 25 : 1220 1228.
41. Dugina TN, Kiseleva EV, Chistow IV, Umarova BA, Strukova SM. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Moscow) 2002 67 : 65 74.
42. Moriyuki K, Nagataki M, Sekiguchi F, Nishikawa H, Kawabata A. Signal transduction for formation/release of interleukin-8 caused by a PAR-2 activating peptide in human lung epithelial cells. Reg Peptides 2008 145 : 42 8.
43. Peng H, Chen P, Cai Y et al. Endothelin-1 increases expression of cyclooxygenase-2 and production of interleukin-8 in human pulmonary epithelial cells. Peptides 2008 29 : 419 424.
44. Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. Wound healing: immunological aspects. Injury 2006 375 : S5 12.
45. Chua F, Laurent GJ. Neutrophil elastase. Mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 2006 3 : 424 427.
46. Lungarella G, Cavarra E, Lucatelli M, Martorana PA. The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol 2008 40 : 1287 1296.
47. Liu C-Y, Liu Y-H, Lin S-M et al. Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment. J Biomed Sci 2003 10 : 746 756.
48. Inbal A, Dardik R. Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair. J Pathophysiol Haemost Thromb 2006 35 : 162 165.
49. Travis J. Structure, function and control of neutrophil proteinases. Am J Med 1988 84 : 37 42.
50. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008 57 : 1 10.
51. D'Amato G, Liccardi G, D'Amato M, Holgate S. Environmental risk factors and allergic bronchial asthma. Clin Exp Allergy 2005 35 : 1113 1124.
52. Mattoli S. Allergen-induced generation of mediators in the mucosa. Env Health Perspect 2001 109 : 553 557.
53. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. The Lancet 2006 368 : 780 793.
54. Persson CGA. Airway epithelium and microcirculation. Eur Respir Rev 1994 4 : 352 362.
55. Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue-factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth. J Thromb Haemostasis 2005 3 : 321 331.
56. Matthay MA, Clements JA. Coagulation-dependent mechanisms and asthma. J Clin Invest 2004 114 : 20 3.
57. Wagers SS, Norton RJ, Rinaldi LM, Bates JHT, Sobel BE, Irvin CG. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004 114 : 104 111.
58. Brims FJ, Chauhan AJ, Higgins B, Shute JK. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Thorax 2009 64 : 1037 1043.
59. Wygracka M, Jablonska E, Guenther A, Preissner KT, Markart P. Current view on alveolar coagulation and fibrinolysis in acute and chronic interstitial lung diseases. Thromb Haemostasis 2008 99 : 494 501.